Off-Label HIV Regimen Data Should Be Provided To Doctors By FDA - Cmte.
Executive Summary
FDA should educate doctors about new HIV regimens to correct potentially misleading information in off-label reprints, members of FDA's Antiviral Drugs Advisory Committee suggested July 25.